USE OF IL-34 TO TREAT RETINAL INFLAMMATION AND NEURODEGENERATION
Technology
E-091-2018
Patent ID
E-091-2018-0-US-06
Country
US
Application Type
National Stage
Patent Status
Pending
Patent Number
Publication Number
US-2021-0009651-A1
Application Number
16/971,288
IC
NEI
Date Filed
Date Issued
Patent PDF